The FDA has been engaged in sustained and ongoing discussions with Gilead Sciences regarding making remdesivir available to patients as quickly as possible, as appropriate, said Michael Felberbaum, an agency spokesman, in an email
Novo Nordisk, which dominates this segment, is expected to expand access and reduce prices to counter new competition, according to industry sources
European Association for the Study of Diabetes (EASD) 60th Annual Meeting
The smell is temporary and harmless
Semaglutide ODT may be useful for patients who prefer a needle-free option, but it should not be assumed to be identical to injectable semaglutide
If you experience any discomfort during use